Kymera Therapeutics, Inc. (KYMR)
119.21
+0.40
(+0.34%)
USD |
NASDAQ |
Sep 01, 16:00
119.21
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Cash from Operations (TTM) : -236.76M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -236.76M |
| March 31, 2026 | -242.58M |
| December 31, 2025 | -232.89M |
| September 30, 2025 | -227.93M |
| June 30, 2025 | -251.01M |
| March 31, 2025 | -234.06M |
| December 31, 2024 | -194.50M |
| September 30, 2024 | -124.67M |
| June 30, 2024 | -106.13M |
| March 31, 2024 | -98.45M |
| December 31, 2023 | -102.83M |
| September 30, 2023 | -150.41M |
| Date | Value |
|---|---|
| June 30, 2023 | -153.03M |
| March 31, 2023 | -156.76M |
| December 31, 2022 | -153.08M |
| September 30, 2022 | -151.90M |
| June 30, 2022 | -154.89M |
| March 31, 2022 | -146.42M |
| December 31, 2021 | -128.95M |
| September 30, 2021 | -110.66M |
| June 30, 2021 | 58.26M |
| March 31, 2021 | 77.36M |
| December 31, 2020 | 88.13M |
| September 30, 2020 | 97.40M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |
| Sarepta Therapeutics, Inc. | 93.95M |
| Anixa Biosciences, Inc. | -7.117M |